Dermatology News

The addition of nivolumab to ipilimumab conferred a long-term OS benefit for patients with advanced melanoma, according to study results presented at ESMO Congress.

Celebrity news and nutrition stories led Healio Dermatology’s most-read articles in August.

Saving money at an early age is perhaps the simplest and one of the most effective methods to accumulate wealth.

Patients with chronic spontaneous urticaria experienced a marked improvement with Dupixent treatment, according to phase 3 trial results released by Regeneron.

The National Psoriasis Foundation has announced the honorees for this year’s Commit to Cure Gala, according to a press release.

Eli Lilly and Company announced it received FDA approval for Ebglyss for the treatment of moderate-to-severe atopic dermatitis that is not well controlled with topical prescription therapies, according to a company press release.

A “simple model” known as ATLAS can help physicians detect recurrent cutaneous melanoma through symptom review, according to researchers.

CHICAGO — Female pattern hair loss is a common condition for menopausal women, but options to reverse and regrow hair are available if patients are diagnosed and treated, according to a speaker at the Annual Meeting of The Menopause Society.

The FDA approved atezolizumab and hyaluronidase-tqjs for subcutaneous injection.

Autologous skin cell suspension transplantation using a cell harvesting device was shown to be effective and well tolerated in vitiligo treatment, according to a study.